Press releases for macular degeneration wet

Wet AMD? Participants Needed Now for New Macular Degeneration Treatment Trials. (2009-01-05)
A new trial has just begun comparing the two Macular Degeneration Wet drugs, Avastin and Lucentis. Currently Lucentis is the FDA approved drug and Avastin has off-label approval. The trial seeks to compare the two drugs for safety and effectiveness. Participants are being recruited now.